These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1777091)

  • 21. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
    Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
    J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A perspective on the dysplastic nevus controversy.
    Piepkorn MW
    Pathology (Phila); 1994; 2(2):259-79. PubMed ID: 9420903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counterpoint: The "dysplastic" nevus: What I do and do not believe.
    Cockerell CJ
    J Am Acad Dermatol; 2015 Sep; 73(3):515-7. PubMed ID: 26282799
    [No Abstract]   [Full Text] [Related]  

  • 25. [Statistical review of Malignant melanoma and its precancerous condition].
    Ueda M; Mishima Y
    Nihon Rinsho; 1993 Jan; 51 Suppl():852-60. PubMed ID: 8459622
    [No Abstract]   [Full Text] [Related]  

  • 26. Current management of melanoma.
    Dunki-Jacobs EM; Callender GG; McMasters KM
    Curr Probl Surg; 2013 Aug; 50(8):351-82. PubMed ID: 23849560
    [No Abstract]   [Full Text] [Related]  

  • 27. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precursor lesions to melanoma.
    Bergman W; Fusaro RM
    Clin Dermatol; 1992; 10(1):21-9. PubMed ID: 1504925
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidence of melanoma in surgically removed pigmented lesions.
    Fernando SS
    Australas J Dermatol; 1987 Dec; 28(3):126-8. PubMed ID: 3504145
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A testable hypothesis in a "borderline" neoplasm.
    LeBoit PE
    Am J Dermatopathol; 2002 Feb; 24(1):89-91. PubMed ID: 11803291
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in the treatment of late stage melanoma.
    Walkington LA; Lorigan P; Danson SJ
    BMJ; 2013 Mar; 346():f1265. PubMed ID: 23460638
    [No Abstract]   [Full Text] [Related]  

  • 33. Point: What's in a name?
    Elder DE
    J Am Acad Dermatol; 2015 Sep; 73(3):513-4. PubMed ID: 26282798
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dysplastic nevus--a precursor melanoma].
    Alanko A; Salo H
    Duodecim; 1987; 103(7):421-5. PubMed ID: 3665790
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Melanoma].
    Bol P
    Ned Tijdschr Tandheelkd; 1999 Jan; 106(1):23-4. PubMed ID: 11930840
    [No Abstract]   [Full Text] [Related]  

  • 37. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
    Newton JA; Bataille V; Griffiths K; Squire JM; Sasieni P; Cuzick J; Bishop DT; Swerdlow A
    J Am Acad Dermatol; 1993 Dec; 29(6):989-96. PubMed ID: 8245266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors in a cohort of patients with multiple primary melanoma.
    McMeniman E; De'Ambrosis K; De'Ambrosis B
    Australas J Dermatol; 2010 Nov; 51(4):254-7. PubMed ID: 21198521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dysplastic pigmented nevi as a high risk group for the development of malignant melanoma].
    Kik A; Kowalewska Z; Pawińska M
    Przegl Dermatol; 1986; 73(4):323-6. PubMed ID: 3333866
    [No Abstract]   [Full Text] [Related]  

  • 40. Skin types in dysplastic nevus syndrome.
    Kopf AW; Goldman RJ; Rivers JK; Levenstein M; Rigel DS; Friedman RJ; Bart RS
    J Dermatol Surg Oncol; 1988 Aug; 14(8):827-31. PubMed ID: 3397442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.